Novel diabetes subgroups show differences in biomarkers of inflammation

Innovative technique developed to destroy cancerous kidney cells
14 April 2021
America’s STD rate at record high again
14 April 2021

Novel diabetes subgroups show differences in biomarkers of inflammation

Chronic inflammation is increasingly a focus of research. A recent study has now identified differences in indicators of inflammation between novel diabetes subgroups. But what does this mean for the future?

Comments are closed.